Welcome to our dedicated page for Visionary Holdings news (Ticker: GV), a resource for investors and traders seeking the latest updates and insights on Visionary Holdings stock.
Visionary Holdings Inc. reports developments tied to its healthcare, biotechnology, and medical-aesthetics focus, including commercialization activity for anti-aging and regenerative wellness products. Company updates have covered V-series anti-aging products, RAMU-related products, Premier Regenerative Complex-President Super Injection, distribution arrangements, channel development, and healthcare service collaborations in markets including China.
Recurring news also includes Nasdaq listing-compliance matters for GV common shares, periodic reporting status, listing-fee notices, shareholder voting matters, governance actions, capital-structure disclosures, and operating and financial results.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Goldfield has successfully completed a cash tender offer for all outstanding shares at $7.00 per share, with 73.83% of shares tendered. This allows First Reserve to merge with Goldfield without additional shareholder votes. Upon completion, Goldfield will become a wholly owned subsidiary, and its common stock will cease trading on the NYSE American. The merger is anticipated to finalize today.